Noritoshi Enatsu
Noritoshi Enatsu has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
Masato Fujisawa
Kobe, Japan
14 shared publicationsKoji Chiba
Hanabusa Women's Clinic Kobe Hyogo Japan
13 shared publicationsHideaki Miyake
Kobe, Japan
12 shared publicationsShoji Kokeguchi
Hanabusa Women's Clinic Kobe Hyogo Japan
11 shared publicationsMasahide Shiotani
Hanabusa Women's Clinic Kobe City Japan
10 shared publicationsKei Matsushita
Kobe, Japan
8 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 25 (1)
Association Between Hydrosalpinx and Detection of Gram‐Positive Anaerobic Cocci in the Endometrial Microbiota: A Single‐Center Retrospective Observational Study
Purpose: To investigate whether hydrosalpinx is associated with alterations in the endometrial microbiota and detection of gram‐positive anaerobic cocci (GPAC)‐associated genera. Methods: This single‐center retrospective observational study included 236 patients who underwent endometrial microbiota testing by 16S ribosomal RNA gene sequencing: 90 with untreated hydrosalpinx diagnosed by hysterosalpingography and 146 without hydrosalpinx. GPAC positivity was defined as detection of at least one of Anaerococcus , Finegoldia , Peptoniphilus , Peptostreptococcus , or Parvimonas . Logistic regression was adjusted for age, antibiotic use within 3 months, and luteal‐phase sampling. False discovery rate adjustment was applied across four exploratory microbiota outcomes. Results: GPAC‐associated genera were detected in 23/90 patients (25.6%) with hydrosalpinx and 19/146 (13.0%) without hydrosalpinx. Hydrosalpinx was nominally associated with GPAC detection (adjusted odds ratio, 2.20; 95% confidence interval, 1.10–4.38; p = 0.025), but not after false discovery rate adjustment ( q = 0.101). No clear associations were observed for the other microbiota outcomes. Similar estimates were obtained after additional adjustment for recurrent implantation failure and in post hoc sensitivity analyses using alternative GPAC definitions. Conclusion: Hydrosalpinx was associated with more frequent detection of GPAC‐associated genera in exploratory analyses. This finding should be considered hypothesis‐generating rather than confirmatory and requires independent prospective validation.
- 1 January 2026
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 25 (1)
Open AccessAssociation Between Hydrosalpinx and Detection of Gram‐Positive Anaerobic Cocci in the Endometrial Microbiota: A Single‐Center Retrospective Observational Study
Purpose: To investigate whether hydrosalpinx is associated with alterations in the endometrial microbiota and detection of gram‐positive anaerobic cocci (GPAC)‐associated genera. Methods: This single‐center retrospective observational study included 236 patients who underwent endometrial microbiota testing by 16S ribosomal RNA gene sequencing: 90 with untreated hydrosalpinx diagnosed by hysterosalpingography and 146 without hydrosalpinx. GPAC positivity was defined as detection of at least one of Anaerococcus , Finegoldia , Peptoniphilus , Peptostreptococcus , or Parvimonas . Logistic regression was adjusted for age, antibiotic use within 3 months, and luteal‐phase sampling. False discovery rate adjustment was applied across four exploratory microbiota outcomes. Results: GPAC‐associated genera were detected in 23/90 patients (25.6%) with hydrosalpinx and 19/146 (13.0%) without hydrosalpinx. Hydrosalpinx was nominally associated with GPAC detection (adjusted odds ratio, 2.20; 95% confidence interval, 1.10–4.38; p = 0.025), but not after false discovery rate adjustment ( q = 0.101). No clear associations were observed for the other microbiota outcomes. Similar estimates were obtained after additional adjustment for recurrent implantation failure and in post hoc sensitivity analyses using alternative GPAC definitions. Conclusion: Hydrosalpinx was associated with more frequent detection of GPAC‐associated genera in exploratory analyses. This finding should be considered hypothesis‐generating rather than confirmatory and requires independent prospective validation.
- Open Access
- 1 January 2026
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 25 (1)
Comparative Effectiveness of Follitropin Delta, Follitropin Alpha, and hMG in ART Cycles: A Single‐Center Retrospective Cohort Study With Propensity Score Matching
Objective: To compare clinical outcomes of ART cycles stimulated with follitropin delta, follitropin alpha, or human menopausal gonadotropin (hMG) using a single‐center retrospective cohort with propensity score matching (PSM). Methods: We analyzed 20 809 ART cycles (2021–2024). PSM adjusted for age, body weight, anti‐Müllerian hormone, antral follicle count, prior ART attempts, stimulation protocol, and trigger method. The matched cohort comprised 7,647 cycles (2549/group). The primary outcome was oocyte yield. Secondary outcomes included blastocyst development, ovarian enlargement ≥ 5 cm, and clinical pregnancy rates. Results: The primary outcome regarding oocyte yield was statistically indeterminate across different analytical approaches, and the observed differences were clinically marginal. Both recombinant FSH preparations showed higher blastocyst yields and a lower observed incidence of ovarian enlargement ≥ 5 cm compared with hMG; the latter finding, however, does not establish a clinical safety advantage because clinically diagnosed OHSS was not evaluated. Clinical pregnancy rates were comparable among the three groups. Conclusions: Differences in oocyte yield among follitropin delta, follitropin alpha, and hMG were small and statistically inconsistent. Secondary findings should be interpreted as exploratory, suggesting broadly comparable clinical performance among the three gonadotropin preparations.
- 1 January 2026
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 25 (1)
Open AccessComparative Effectiveness of Follitropin Delta, Follitropin Alpha, and hMG in ART Cycles: A Single‐Center Retrospective Cohort Study With Propensity Score Matching
Objective: To compare clinical outcomes of ART cycles stimulated with follitropin delta, follitropin alpha, or human menopausal gonadotropin (hMG) using a single‐center retrospective cohort with propensity score matching (PSM). Methods: We analyzed 20 809 ART cycles (2021–2024). PSM adjusted for age, body weight, anti‐Müllerian hormone, antral follicle count, prior ART attempts, stimulation protocol, and trigger method. The matched cohort comprised 7,647 cycles (2549/group). The primary outcome was oocyte yield. Secondary outcomes included blastocyst development, ovarian enlargement ≥ 5 cm, and clinical pregnancy rates. Results: The primary outcome regarding oocyte yield was statistically indeterminate across different analytical approaches, and the observed differences were clinically marginal. Both recombinant FSH preparations showed higher blastocyst yields and a lower observed incidence of ovarian enlargement ≥ 5 cm compared with hMG; the latter finding, however, does not establish a clinical safety advantage because clinically diagnosed OHSS was not evaluated. Clinical pregnancy rates were comparable among the three groups. Conclusions: Differences in oocyte yield among follitropin delta, follitropin alpha, and hMG were small and statistically inconsistent. Secondary findings should be interpreted as exploratory, suggesting broadly comparable clinical performance among the three gonadotropin preparations.
- Open Access
- 29 July 2025
- Published by Elsevier in F&S Reports
- Vol. 6 (4) , 446-454
Optimal timing for triggering oocyte maturation during in vitro fertilization cycles varies between gonadotropin-releasing hormone agonist and human chorionic gonadotropin use
- 29 July 2025
- Published by Elsevier in F&S Reports
- Vol. 6 (4) , 446-454
Open AccessOptimal timing for triggering oocyte maturation during in vitro fertilization cycles varies between gonadotropin-releasing hormone agonist and human chorionic gonadotropin use
- Open Access
- 1 January 2025
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 24 (1)
Migration–Gravity Sedimentation: An Effective Approach for Reducing Sperm DNA Fragmentation With Comparable Intracytoplasmic Sperm Injection Outcomes Compared to Density Gradient Centrifugation
Purpose: To compare the efficacy of migration–gravity sedimentation (MGS) and density gradient centrifugation (DGC) for sperm preparation in intracytoplasmic sperm injection (ICSI) cycles, focusing on sperm DNA fragmentation (SDF) and ICSI outcomes. Methods: In this prospective study, 32 patients who underwent ICSI using sibling oocytes were enrolled. Half of the oocytes were fertilized with DGC‐prepared sperm and the other half with MGS‐prepared sperm. Semen parameters were assessed using computer‐assisted sperm analysis (CASA), and SDF levels were measured using the terminal deoxynucleotidyl transferase dUTP nick end labeling assay before and after sperm preparation. Fertilization, blastocyst development, and clinical pregnancy rates were compared between the two groups. Results: MGS significantly reduced SDF levels compared to raw semen and DGC. CASA demonstrated enhanced motility, straightness, and linearity with MGS, although curvilinear velocity, average path velocity, and amplitude of lateral head displacement were lower. Fertilization and clinical outcomes, including blastocyst formation and pregnancy rates, were comparable between the groups. Conclusion: MGS is a simple, centrifuge‐free, and low‐cost sperm preparation technique that effectively reduces sperm DNA fragmentation and achieves ICSI outcomes similar to those of DGC. These findings indicate that MGS may be a viable alternative to assisted reproductive technology, specifically in patients without male‐factor infertility. Trial Registration: This study was registered in the University Hospital Medical Information Network (UMIN000043585)
- 1 January 2025
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 24 (1)
Open AccessMigration–Gravity Sedimentation: An Effective Approach for Reducing Sperm DNA Fragmentation With Comparable Intracytoplasmic Sperm Injection Outcomes Compared to Density Gradient Centrifugation
Purpose: To compare the efficacy of migration–gravity sedimentation (MGS) and density gradient centrifugation (DGC) for sperm preparation in intracytoplasmic sperm injection (ICSI) cycles, focusing on sperm DNA fragmentation (SDF) and ICSI outcomes. Methods: In this prospective study, 32 patients who underwent ICSI using sibling oocytes were enrolled. Half of the oocytes were fertilized with DGC‐prepared sperm and the other half with MGS‐prepared sperm. Semen parameters were assessed using computer‐assisted sperm analysis (CASA), and SDF levels were measured using the terminal deoxynucleotidyl transferase dUTP nick end labeling assay before and after sperm preparation. Fertilization, blastocyst development, and clinical pregnancy rates were compared between the two groups. Results: MGS significantly reduced SDF levels compared to raw semen and DGC. CASA demonstrated enhanced motility, straightness, and linearity with MGS, although curvilinear velocity, average path velocity, and amplitude of lateral head displacement were lower. Fertilization and clinical outcomes, including blastocyst formation and pregnancy rates, were comparable between the groups. Conclusion: MGS is a simple, centrifuge‐free, and low‐cost sperm preparation technique that effectively reduces sperm DNA fragmentation and achieves ICSI outcomes similar to those of DGC. These findings indicate that MGS may be a viable alternative to assisted reproductive technology, specifically in patients without male‐factor infertility. Trial Registration: This study was registered in the University Hospital Medical Information Network (UMIN000043585)
- Open Access
- 1 January 2024
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 23 (1) , e12579
Differences in clinical outcomes between men with mosaic Klinefelter syndrome and those with non‐mosaic Klinefelter syndrome
Purpose: This study compared the clinical outcomes of men with Klinfelter syndrome based on karyotype.Methods: The authors analyzed the outcomes of microdissection testicular sperm extraction (micro‐TESE) performed on 57 patients with Klinfelter syndrome (KS) at our clinic.Results: The average ages of the non‐mosaic and mosaic KS groups were 32.2 ± 4.8 and 45.9 ± 13.1 years, respectively. The sperm retrieval rates of the non‐mosaic and mosaic KS groups were 46.5% (20/43) and 50.0% (7/14), respectively. The fertilization rates after intracytoplasmic sperm injection did not significantly differ between the non‐mosaic and mosaic KS groups. The mosaic KS group had higher cleavage and blastocyst development rates than the non‐mosaic KS group (72.2% vs. 96.2% and 30.5% vs. 44.7%, respectively). The group using motile sperm had better outcomes than the group using immotile sperm. The embryo transfer outcomes of the non‐mosaic and mosaic KS groups did not significantly differ (clinical pregnancy rate: 28.0% vs. 20.7%, miscarriage rate: 14.3% vs. 33.3%, production rate per transfer: 22.0% vs. 13.8%, and production rate per case: 58.8% vs. 57.1%).Conclusions: Compared with the non‐mosaic KS group, the mosaic KS group had significantly better intracytoplasmic sperm injection outcomes because of the higher utilization rate of motile sperm.
- 1 January 2024
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 23 (1) , e12579
Open AccessDifferences in clinical outcomes between men with mosaic Klinefelter syndrome and those with non‐mosaic Klinefelter syndrome
Purpose: This study compared the clinical outcomes of men with Klinfelter syndrome based on karyotype.Methods: The authors analyzed the outcomes of microdissection testicular sperm extraction (micro‐TESE) performed on 57 patients with Klinfelter syndrome (KS) at our clinic.Results: The average ages of the non‐mosaic and mosaic KS groups were 32.2 ± 4.8 and 45.9 ± 13.1 years, respectively. The sperm retrieval rates of the non‐mosaic and mosaic KS groups were 46.5% (20/43) and 50.0% (7/14), respectively. The fertilization rates after intracytoplasmic sperm injection did not significantly differ between the non‐mosaic and mosaic KS groups. The mosaic KS group had higher cleavage and blastocyst development rates than the non‐mosaic KS group (72.2% vs. 96.2% and 30.5% vs. 44.7%, respectively). The group using motile sperm had better outcomes than the group using immotile sperm. The embryo transfer outcomes of the non‐mosaic and mosaic KS groups did not significantly differ (clinical pregnancy rate: 28.0% vs. 20.7%, miscarriage rate: 14.3% vs. 33.3%, production rate per transfer: 22.0% vs. 13.8%, and production rate per case: 58.8% vs. 57.1%).Conclusions: Compared with the non‐mosaic KS group, the mosaic KS group had significantly better intracytoplasmic sperm injection outcomes because of the higher utilization rate of motile sperm.
- Open Access
- 1 January 2022
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 21 (1) , e12443
A novel system based on artificial intelligence for predicting blastocyst viability and visualizing the explanation
Purpose: The purpose of the study was to invent and evaluate the novel artificial intelligence (AI) system named Fertility image Testing Through Embryo (FiTTE) for predicting blastocyst viability and visualizing the explanations via gradient‐based localization.Methods: The authors retrospectively analyzed 19 342 static blastocyst images with related inspection histories from 9961 infertile patients who underwent in vitro fertilization. Among these data, 17 984 cycles of single‐blastocyst transfer were used for training, and data from 1358 cycles were used for testing purposes.Results: The prediction accuracy for clinical pregnancy achieved by a control model using conventional Gardner scoring system was 59.8%, and area under the curve (AUC) was 0.62. FiTTE improved the prediction accuracy by using blastocyst images to 62.7% and AUC of 0.68. Additionally, the accuracy achieved by an ensemble model using image plus clinical data was 65.2% and AUC was 0.71, representing an improvement in prediction accuracy. The visualization algorithm showed brighter colors with blastocysts that resulted in clinical pregnancy.Conclusions: The authors invented the novel AI system, FiTTE, which could provide more precise prediction of the probability of clinical pregnancy using blastocyst images secondary to single embryo transfer than the conventional Gardner scoring assessments. FiTTE could also provide explanation of AI prediction using colored blastocyst images.
- 1 January 2022
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 21 (1) , e12443
Open AccessA novel system based on artificial intelligence for predicting blastocyst viability and visualizing the explanation
Purpose: The purpose of the study was to invent and evaluate the novel artificial intelligence (AI) system named Fertility image Testing Through Embryo (FiTTE) for predicting blastocyst viability and visualizing the explanations via gradient‐based localization.Methods: The authors retrospectively analyzed 19 342 static blastocyst images with related inspection histories from 9961 infertile patients who underwent in vitro fertilization. Among these data, 17 984 cycles of single‐blastocyst transfer were used for training, and data from 1358 cycles were used for testing purposes.Results: The prediction accuracy for clinical pregnancy achieved by a control model using conventional Gardner scoring system was 59.8%, and area under the curve (AUC) was 0.62. FiTTE improved the prediction accuracy by using blastocyst images to 62.7% and AUC of 0.68. Additionally, the accuracy achieved by an ensemble model using image plus clinical data was 65.2% and AUC was 0.71, representing an improvement in prediction accuracy. The visualization algorithm showed brighter colors with blastocysts that resulted in clinical pregnancy.Conclusions: The authors invented the novel AI system, FiTTE, which could provide more precise prediction of the probability of clinical pregnancy using blastocyst images secondary to single embryo transfer than the conventional Gardner scoring assessments. FiTTE could also provide explanation of AI prediction using colored blastocyst images.
- 1 January 2022
- Published by Elsevier in Fertility and Sterility
- Vol. 117 (1) , 213-220
Developmental trajectory of monopronucleated zygotes after in vitro fertilization when they include both male and female genomes
- 1 January 2022
- Published by Elsevier in Fertility and Sterility
- Vol. 117 (1) , 213-220
Developmental trajectory of monopronucleated zygotes after in vitro fertilization when they include both male and female genomes
- Open Access
- 1 November 2021
- Published by Knowledge E DMCC in Journal of Reproduction & Infertility
- Vol. 22 (4) , 251-257
Clinical Outcomes of Rescue Intracytoplasmic Sperm Injection at Different Timings Following In Vitro Fertilization
Background: Although rescue intracytoplasmic sperm injection (r-ICSI) is extensively used worldwide, the indication of r-ICSI and its optimal timing remains obscure. This study aimed to assess the outcomes of r-ICSI following in vitro fertilization in different timings when fertilization is confirmed. Methods: This study included 5,156 cycles (47,785 eggs). Fertilization was confirmed by polar body analysis after 4 and 6 hr of coincubation of the sperm and oocyte. Oocytes that underwent IVF were divided into two groups based on the time when a second polar body was detected in more than 30% of all oocytes (Four-hr group and six-hr group). If the second polar body was not detected or was present in less than 30% of all oocytes after six hr of coincubation, rescue-ICSI (r-ICSI) was performed for oocytes without a second polar body (r-ICSI group). Results: The fertilization rates of two pronuclear (2PN) oocytes in the three groups (Four-hr group, six-hr group, and r-ICSI group) were 70.7%, 51.3%, and 58.0%, respectively. The blastocyst formation rates were 62.8%, 53.4%, and 42.9%, respectively. Conclusion: Performing r-ICSI after six hr of coincubation can salvage cases with fertilization failure in IVF. The higher fertilization rate of r-ICSI indicates that all oocytes without signs of fertilization after six hr of coincubation should undergo r-ICSI.
- 1 November 2021
- Published by Knowledge E DMCC in Journal of Reproduction & Infertility
- Vol. 22 (4) , 251-257
Open AccessClinical Outcomes of Rescue Intracytoplasmic Sperm Injection at Different Timings Following In Vitro Fertilization
Background: Although rescue intracytoplasmic sperm injection (r-ICSI) is extensively used worldwide, the indication of r-ICSI and its optimal timing remains obscure. This study aimed to assess the outcomes of r-ICSI following in vitro fertilization in different timings when fertilization is confirmed. Methods: This study included 5,156 cycles (47,785 eggs). Fertilization was confirmed by polar body analysis after 4 and 6 hr of coincubation of the sperm and oocyte. Oocytes that underwent IVF were divided into two groups based on the time when a second polar body was detected in more than 30% of all oocytes (Four-hr group and six-hr group). If the second polar body was not detected or was present in less than 30% of all oocytes after six hr of coincubation, rescue-ICSI (r-ICSI) was performed for oocytes without a second polar body (r-ICSI group). Results: The fertilization rates of two pronuclear (2PN) oocytes in the three groups (Four-hr group, six-hr group, and r-ICSI group) were 70.7%, 51.3%, and 58.0%, respectively. The blastocyst formation rates were 62.8%, 53.4%, and 42.9%, respectively. Conclusion: Performing r-ICSI after six hr of coincubation can salvage cases with fertilization failure in IVF. The higher fertilization rate of r-ICSI indicates that all oocytes without signs of fertilization after six hr of coincubation should undergo r-ICSI.
- Open Access
- 30 September 2021
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 21 (1) , e12417
Clinical outcome of intrauterine infusion of platelet‐rich plasma in patients with recurrent implantation failure
Purpose: This study aimed to evaluate the effectiveness of intrauterine infusion of platelet‐rich plasma (PRP) before embryo transfer (ET) in recurrent implantation failure (RIF) cases.Methods: The authors retrospectively analyzed 54 ET cycles involving frozen and thawed high‐quality blastocysts after intrauterine PRP infusion between September 2019 and November 2020. All patients had a history of at least two times of implantation failure on ET. A total of 54 patients were categorized into two groups: thin endometrium (39 patients) and unexplained implantation failure (15 patients). In the thin‐endometrium group, the endometrial thickness (EMT) was <8.0 mm at cycle days 12–14 in the prior ET cycle.Results: Among the 54 ET cycles after PRP infusion, 31 (57.4%) were positive for human chorionic gonadotropin (hCG) and 27 (50%) achieved clinical pregnancy, which was significantly better than that in prior ET cycles without PRP infusion (27.2% and 9.6%, respectively). The EMT was not increased at ET date on the PRP cycle compared with that in the prior ET cycle in both patient groups. Moreover, EMT was not different between the hCG‐positive and hCG‐negative groups.Conclusion: Although intrauterine PRP infusion had no superior effect on increasing the EMT than conventional therapeutic agents, it resulted in high pregnancy rates in patients experiencing RIF with or without thin endometrium.
- 30 September 2021
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 21 (1) , e12417
Open AccessClinical outcome of intrauterine infusion of platelet‐rich plasma in patients with recurrent implantation failure
Purpose: This study aimed to evaluate the effectiveness of intrauterine infusion of platelet‐rich plasma (PRP) before embryo transfer (ET) in recurrent implantation failure (RIF) cases.Methods: The authors retrospectively analyzed 54 ET cycles involving frozen and thawed high‐quality blastocysts after intrauterine PRP infusion between September 2019 and November 2020. All patients had a history of at least two times of implantation failure on ET. A total of 54 patients were categorized into two groups: thin endometrium (39 patients) and unexplained implantation failure (15 patients). In the thin‐endometrium group, the endometrial thickness (EMT) was <8.0 mm at cycle days 12–14 in the prior ET cycle.Results: Among the 54 ET cycles after PRP infusion, 31 (57.4%) were positive for human chorionic gonadotropin (hCG) and 27 (50%) achieved clinical pregnancy, which was significantly better than that in prior ET cycles without PRP infusion (27.2% and 9.6%, respectively). The EMT was not increased at ET date on the PRP cycle compared with that in the prior ET cycle in both patient groups. Moreover, EMT was not different between the hCG‐positive and hCG‐negative groups.Conclusion: Although intrauterine PRP infusion had no superior effect on increasing the EMT than conventional therapeutic agents, it resulted in high pregnancy rates in patients experiencing RIF with or without thin endometrium.
- Open Access
- 11 March 2020
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 19 (2) , 182-188
Predictive factors influencing pregnancy rate in frozen embryo transfer
Purpose: To evaluate the outcomes of embryo transfer (ET) and to identify the parameters influencing pregnancy outcomes.Methods: This study included 938 ET cycles involving single frozen and thawed good‐quality blastocyst (Gardner grade ≥3BB) between August 2017 and January 2018. The significance of several parameters including endometrial thickness, position of the transferred air bubble, self‐evaluation score by physicians, and uterus direction at ET as predictors of clinical pregnancy was evaluated using univariate and multivariate analyses.Results: Among 938 ET cycles, 462 (49.3%) resulted in a clinical pregnancy. Endometrial thickness was positively associated with clinical pregnancy in a linear trend. Between the variable position of the transferred air bubble and clinical pregnancy rate showed a curvilinear relationship. Clinical pregnancy rate was higher in cases with good self‐evaluation score, whereas there was no difference between groups with different uterus directions. Univariate analysis of predictive parameters identified endometrial thickness, self‐evaluation score by physicians, and position of air bubbles as significant predictors of clinical pregnancy, of which endometrial thickness and position of air bubbles appeared to be independently related to clinical pregnancy.Conclusion: Endometrial thickness and the position of transferred air bubbles influenced clinical pregnancy in ET cycles.
- 11 March 2020
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 19 (2) , 182-188
Open AccessPredictive factors influencing pregnancy rate in frozen embryo transfer
Purpose: To evaluate the outcomes of embryo transfer (ET) and to identify the parameters influencing pregnancy outcomes.Methods: This study included 938 ET cycles involving single frozen and thawed good‐quality blastocyst (Gardner grade ≥3BB) between August 2017 and January 2018. The significance of several parameters including endometrial thickness, position of the transferred air bubble, self‐evaluation score by physicians, and uterus direction at ET as predictors of clinical pregnancy was evaluated using univariate and multivariate analyses.Results: Among 938 ET cycles, 462 (49.3%) resulted in a clinical pregnancy. Endometrial thickness was positively associated with clinical pregnancy in a linear trend. Between the variable position of the transferred air bubble and clinical pregnancy rate showed a curvilinear relationship. Clinical pregnancy rate was higher in cases with good self‐evaluation score, whereas there was no difference between groups with different uterus directions. Univariate analysis of predictive parameters identified endometrial thickness, self‐evaluation score by physicians, and position of air bubbles as significant predictors of clinical pregnancy, of which endometrial thickness and position of air bubbles appeared to be independently related to clinical pregnancy.Conclusion: Endometrial thickness and the position of transferred air bubbles influenced clinical pregnancy in ET cycles.